Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Xitllaly Popa"'
Autor:
Elia Neninger, Tania Crombet, Agustin Lage, Zaima Mazorra, Gryssell Rodríguez, Patricia Sierra, Yaisel Pomares, Nadia Aguilera, Jenelin Parra, Liuba Alonso, Maria A. Marrero, Patricia Lorenzo-Luaces, Carmen Viada, Beatriz Garcia, Yoanna I. Flores, Mauricio Catala, Teresa Sabates, Niurka Futiel, Delmairis Reyes, Loisel Vello, Lina Arzuaga, Mireysi Cala, Ana de la Torre, Gala N. Romero, Yanine Otero, Soraida C. Acosta, Ricardo Fleytas, Rosa M. Amador, Tatiana Crespo, Eduardo Santiesteban, Silvia Mendoza, Odeth Martínez, Xitllaly Popa, Pedro C. Rodriguez
CONSORT Diagram (PP = Per Protocol Population).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8332e598cd21c7f06929c52df9b06517
https://doi.org/10.1158/1078-0432.22456923
https://doi.org/10.1158/1078-0432.22456923
Autor:
Elia Neninger, Tania Crombet, Agustin Lage, Zaima Mazorra, Gryssell Rodríguez, Patricia Sierra, Yaisel Pomares, Nadia Aguilera, Jenelin Parra, Liuba Alonso, Maria A. Marrero, Patricia Lorenzo-Luaces, Carmen Viada, Beatriz Garcia, Yoanna I. Flores, Mauricio Catala, Teresa Sabates, Niurka Futiel, Delmairis Reyes, Loisel Vello, Lina Arzuaga, Mireysi Cala, Ana de la Torre, Gala N. Romero, Yanine Otero, Soraida C. Acosta, Ricardo Fleytas, Rosa M. Amador, Tatiana Crespo, Eduardo Santiesteban, Silvia Mendoza, Odeth Martínez, Xitllaly Popa, Pedro C. Rodriguez
Related adverse events in the vaccine arm. Number of adverse events.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68de23a097d2c9df7186d694c2019444
https://doi.org/10.1158/1078-0432.22456920.v1
https://doi.org/10.1158/1078-0432.22456920.v1
Autor:
Elia Neninger, Tania Crombet, Agustin Lage, Zaima Mazorra, Gryssell Rodríguez, Patricia Sierra, Yaisel Pomares, Nadia Aguilera, Jenelin Parra, Liuba Alonso, Maria A. Marrero, Patricia Lorenzo-Luaces, Carmen Viada, Beatriz Garcia, Yoanna I. Flores, Mauricio Catala, Teresa Sabates, Niurka Futiel, Delmairis Reyes, Loisel Vello, Lina Arzuaga, Mireysi Cala, Ana de la Torre, Gala N. Romero, Yanine Otero, Soraida C. Acosta, Ricardo Fleytas, Rosa M. Amador, Tatiana Crespo, Eduardo Santiesteban, Silvia Mendoza, Odeth Martínez, Xitllaly Popa, Pedro C. Rodriguez
Overview of all adverse events in the safety evaluable population.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cdcd948022a91a74f0627d93a7352c4
https://doi.org/10.1158/1078-0432.22456914.v1
https://doi.org/10.1158/1078-0432.22456914.v1
Autor:
Ricardo Fleytas, Yoanna I. Flores, Zaima Mazorra, Jenelin Parra, Niurka Futiel, Lina Arzuaga, Odeth Martínez, Maria A. Marrero, Mauricio Catala, Carmen Viada, Delmairis Reyes, Loisel Vello, Silvia Mendoza, Gryssell Rodriguez, Patricia Sierra, Nadia Aguilera, Pedro C. Rodriguez, Tatiana Crespo, Yaisel Pomares, Liuba Alonso, Teresa Sabates, Mireysi Cala, Eduardo Santiesteban, Yanine Otero, Beatriz García, Tania Crombet, Soraida Acosta, Agustin Lage, Rosa Maria Amador, Patricia Lorenzo-Luaces, Gala N. Romero, Xitllaly Popa, Elia Neninger, Ana de la Torre
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 22(15)
Purpose: EGFR is a well-validated target for patients with non–small cell lung cancer (NSCLC). CIMAvax-EGF is a therapeutic cancer vaccine composed of human recombinant EGF conjugated to a carrier protein and Montanide ISA51 as adjuvant. The vaccin